Hot signal

Submit
Hot signal
Training on the Benefits of Parallel Imports for Patients

Training on the Benefits of Parallel Imports for Patients

BAMPTD participated with a lecture at the Annual Conference of the Federation of Bulgarian Patient Forum in Sandanski Patient training on Parallel Distribution and the possibilities of Parallel...
Broken rhythm of drug imports and withdrawal of products from Bulgaria -  leading causes for patient alerts

Broken rhythm of drug imports and withdrawal of products from Bulgaria - leading causes for patient alerts

his shows the aggregated annual data from the BAMPTD online shortage drug search platform 450 drugs were searched for one year on the online patient signaling platform, which was created and...
62% of drug shortage can be solved with parallel imports

62% of drug shortage can be solved with parallel imports

Parallel imports of medicines is an effective solution in case of shortage of the national market - it is the solution for 62% of the cases of missing medicines, said Boryana Marinkova, Executive...

Our Goals

To generate savings on public and private funds for medicines.

To inform the patients and healthcare professionals about the benefits of parallel distribution of medicines.

To work through the activities of his members to provide access to missing medicines on the Bulgarian market.

To provide conditions for fast delivery of medicines at a lower price to Bulgarian patients.

To promotes and develop good practices and high quality standards in parallel distribution of medicines.

Bulgarian Association for Medicines Parallel Trade Development

The Bulgarian Association for Medicines Parallel Trade Development was established in November 2013 in Sofia.

The members of the Bulgarian Association for the Development of Parallel Drug Marketing are also members of the European Association of Euro-pharmaceutical Companies (EAEPC), which is the European Commission's regulated partner advocating the idea of parallel drug trade in the EU. EAEPC brings together more than 70 parallel drug dealers across 20 European Economic Area (EEA) countries.